IDERA PHARMACEUTICALS INC - COM PAR (IDRA)

CUSIP: 45168K405

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM PAR
Total 13F shares
3,721,326
Share change
-518,081
Total reported value
$1,858,000
Price per share
$0.50
Number of holders
24
Value change
-$271,580
Number of buys
5
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 45168K405?
CUSIP 45168K405 identifies IDRA - IDERA PHARMACEUTICALS INC - COM PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IDERA PHARMACEUTICALS INC - COM PAR (IDRA) as of Q1 2022

As of 31 Mar 2022, IDERA PHARMACEUTICALS INC - COM PAR (IDRA) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,721,326 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, HOLLENCREST CAPITAL MANAGEMENT, MORGAN STANLEY, GROUP ONE TRADING, L.P., STATE STREET CORP, COMMONWEALTH EQUITY SERVICES, LLC, and NORTHERN TRUST CORP. This page lists 24 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.